Evidence map›Paper›PMID 41398158›Full record

ArticleNature communications2025

Partial restoration of mitochondrial dysfunction by AAV-Ant1 protects from dilated cardiomyopathy in Ant1

Alessia Angelin, Kierstin Keller, Peiran Lu, Joseph W Guarnieri, Gabrielle A Widjaja, Rasheed Sule, Kevin Janssen, Arnold Olali, Zimu Cen, Valeria Carosi and 5 more

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Alessia AngelinCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-7115-5451
Kierstin KellerCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Peiran LuCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0009-0001-5096-3046
Joseph W GuarnieriCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Gabrielle A WidjajaCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Rasheed SuleCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kevin JanssenCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-6980-9575
Arnold OlaliCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Zimu CenCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0009-0003-4732-6366
Valeria CarosiCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Maina BeauplanCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Deborah G MurdockCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Prasanth PotluriCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Liming PeiCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. lpei@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-1924-0333
Douglas C WallaceCenter for Mitochondrial and Epigenomic Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. WallaceD1@chop.edu.ORCID http://orcid.org/0000-0002-7480-8278

Funding

Organ Specific Project - HeartU54HL165442 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI MOFFITT, JEFFREY, PEI, LIMING · 2022 to 2025
$7.6M
Role of Adaptive Immunity in Etiology of Alzheimer’s Disease andAlzheimer’s Disease-Related DementiasR01AG078814 · NIA · CHILDREN'S HOSP OF PHILADELPHIA · PI Douglas C Wallace · 2022 to 2026
$4.2M
Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNAR01CA259635 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI Douglas C Wallace · 2022 to 2026
$3.2M
Novel biological insights by utilizing mitochondrial genome information from HuBMAP resourcesU01HL166058 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI PEI, LIMING, WALLACE, DOUGLAS C · 2022 to 2025
$2.1M
Coordinated regulation of mitochondrial and cellular functions by nuclear receptorsR01DK111495 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI PEI, LIMING · 2017 to 2021
$2.0M
American Heart Association (American Heart Association, Inc.) 227477American Heart Association (American Heart Association, Inc.) 23DIVSUP1069865NCI NIH HHS R01 CA259635NHLBI NIH HHS U01 HL166058NHLBI NIH HHS U54 HL165442NIA NIH HHS R01 AG078814NIDDK NIH HHS R01 DK111495U.S. Department of Defense (United States Department of Defense) W81XWH22-1-0058U.S. Department of Defense (United States Department of Defense) W81XWH22-1-0560U.S. Department of Defense (United States Department of Defense) W81XWH22-1-0561U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AG078814U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01CA259635U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01DK111495U.S. Department of Health & Human Services | National Institutes of Health (NIH) U01HL166058U.S. Department of Health & Human Services | National Institutes of Health (NIH) U54HL165442
6 · The paper itself

Abstract

Primary mitochondrial disease (PMD) patients manifesting cardiomyopathy are twice as likely to die as other PMD patients. One PMD with cardiomyopathy is caused by null mutations in the heart-muscle isoform of the adenine nucleotide translocator (SLC25A4, ANT1) gene, with the severity of cardiomyopathy mediated by mitochondrial DNA. To optimize strategies for addressing mitochondrial cardiomyopathy, we generated an Ant1 null mouse and combined it with the ND6

Indexed as

Adenine Nucleotide Translocator 1Cardiomyopathy, DilatedDNA, MitochondrialMitochondria, HeartAnimalsDependovirusDisease Models, AnimalGenetic TherapyHumansMaleMiceMice, KnockoutMutationMyocardiumPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAdenine Nucleotide Translocator 1DNA, MitochondrialPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha

Identifiers

PMID41398158
PMCPMC12800341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.